EPW
GOSS icon

Evolve Private Wealth’s Gossamer Bio GOSS Stock Holding History

Evolve Private Wealth’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Buy
+17,643
New +$4.92K ﹤0.01% 1002

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Evolve Private Wealth's GOSS Position: Q2 2026 in Review

Evolve Private Wealth opened a new position in Gossamer Bio (GOSS) in Q2 2026: 17,643 shares worth $2.9K. The stake represents ﹤0.01% of the portfolio and ranks #1002 among its holdings.

170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Evolve Private Wealth held 17,643 shares of Gossamer Bio worth $2.9K as of Q2 2026.
  • Gossamer Bio was a new Evolve Private Wealth position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Evolve Private Wealth's portfolio in Q2 2026, its #1002 holding.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.